Urbano
Anido Herranz
University College London Hospitals NHS Foundation Trust
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de University College London Hospitals NHS Foundation Trust (1)
2022
-
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
European Urology, Vol. 82, Núm. 2, pp. 212-222